Company intelligence / Profile preview

Injectpower

France

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Injectpower has demonstrated the manufacturability and 10+ year performance of its ultra-miniature, high-density rechargeable micro-battery for powering implantable medical sensors, enabling continuous, autonomous monitoring. The technology has been validated in pre-clinical and integration demonstrations, with industrial production targeted to begin in 2026. Over 1 million microbatteries have been produced to date for integration and technology demonstration purposes.

Therapeutic areas: NeurologyOphthalmologyCardiovascularOther
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

CEA-LetiInjectsenseBPI France

Beyond the preview

Go deeper on Injectpower.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Injectpower.

Explore the full profile